TARA — PROTARA THERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  8 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in PROTARA THERAPEUTICS INC (TARA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.62% (2025 Q1)
Avg. % of fund
0.6%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 363,666 -780,011 -68.2% 0.32% $1.6M $4.35
2025 Q2 REDUCED 1,143,677 -46,902 -3.9% 1.11% $3.5M $3.03
2025 Q1 ADDED 1,190,579 +858,185 +258.2% 1.62% $5.1M $4.26
2024 Q4 REDUCED 332,394 -610,463 -64.7% 0.44% $1.8M $5.28
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TARA price (monthly, adj. close)

Other funds also holding TARA

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 8.76% ACORN CAPITAL ADVISORS, LLC 3.16% 5AM Venture Management, LLC 3Y 2.3% Sio Capital Management, LLC 3Y 7Y 1.44% Catalio Capital Management, LP 1.36% SUPERSTRING CAPITAL MANAGEMENT LP 1.03% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.67% Integral Health Asset Management, LLC 3Y 0.6% ADAR1 Capital Management, LLC 0.44% Monashee Investment Management LLC 3Y 7Y 0.38%
← Back to STEMPOINT CAPITAL LP Holdings